RRoche Read More FDA approves new breast cancer drug, a new option for some patients2026-11-16 Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
NNovartis Read More Zolgensma gene therapy link to tumor risk ‘will change the calculus’2026-11-10 For two decades, researchers debated whether adeno-associated viruses, the small viruses used to deliver new genes into thousands…
NNovartis Read More Pharmalittle: Novartis abandons heart drug, BIO fights Medicare pilot2026-11-09 Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
NNovartis Read More Lp(a) drug lowers heart risk marker but not adverse heart events2026-11-07 CHICAGO — Lipoprotein(a), a genetic risk factor for cardiovascular disease carried by 1 in 5 people, is the…
NNovartis Read More Pharmalittle: Tumors found in kids treated with Novartis SMA drug2026-11-06 And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
NNovartis Read More Novartis cites previously unknown tumor cases possibly tied to gene therapy2026-11-05 Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
NNovartis Read More Novartis cites previously unknown tumor cases possibly tied to gene therapy2026-11-05 Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
RRoche Read More Roche’s lung cancer drug divarasib shows impressive data2026-10-26 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
RRoche Read More Pharmalittle: Roche reports lung cancer data; CAR-T trial death noted2026-10-26 Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…
NNovartis Read More Novartis MS treatment cuts rates of relapse in pivotal trials2026-10-23 Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
RRoche Read More Pharmalittle: U.S-China biotech deals to get added scrutiny2026-10-22 Top of the morning to you. Blue skies, cool breezes, and plenty of chirping birds are enveloping the…
NNovartis Read More Muscular dystrophy therapy is available, but only to a fortunate few2026-10-08 There’s a boy like you in Minnesota, Yannick’s mom told him a few years ago. He has the…